Calcineurin regulates innate antifungal immunity in neutrophils

Matthew B Greenblatt, Antonios Aliprantis, Bella Hu, Laurie H Glimcher, Matthew B Greenblatt, Antonios Aliprantis, Bella Hu, Laurie H Glimcher

Abstract

Patients taking immunosuppressive drugs, like cyclosporine A (CsA), that inhibit calcineurin are highly susceptible to disseminated fungal infections, although it is unclear how these drugs suppress resistance to these opportunistic pathogens. We show that in a mouse model of disseminated Candida albicans infection, CsA-induced susceptibility to fungal infection maps to the innate immune system. To further define the cell types targeted by CsA, we generated mice with a conditional deletion of calcineurin B (CnB) in neutrophils. These mice displayed markedly decreased resistance to infection with C. albicans, and both CnB-deficient and CsA-treated neutrophils showed a defect in the ex vivo killing of C. albicans. In response to the fungal-derived pathogen-associated molecular pattern zymosan, neutrophils lacking CnB displayed impaired up-regulation of genes (IL-10, Cox2, Egr1, and Egr2) regulated by nuclear factor of activated T cells, the best characterized CnB substrate. This activity was Myd88 independent and was reproduced by stimulation with the beta(1,3) glucan curdlan, indicating that dectin-1, rather than toll-like receptors, is the upstream activator of calcineurin. Our results suggest that disseminated fungal infections seen in CsA-treated patients are not just a general consequence of systemic suppression of adaptive immunity but are, rather, a result of the specific blockade of evolutionarily conserved innate pathways for fungal resistance.

Figures

Figure 1.
Figure 1.
CsA suppresses innate resistance to C. albicans infection. (A) Kaplan-Meier survival curve showing the survival of C. albicans–infected mice. Rag2−/− or WT control mice were infected with 105C. albicans yeasts by i.v. injection and then treated daily with 200 mg/kg CsA or vehicle control (n = 11–12 mice per group). Mice were then monitored daily for survival. P < 0.0001 by log-rank test comparing CsA-treated to vehicle-treated groups, with no significant difference between either Rag2−/− or WT groups. Results are representative of three independent experiments. (B) Mice were infected as in A and histological analysis of the kidneys was performed 4 d after infection. C. albicans were visualized by PAS stain (purple, arrow). Histology is representative of four per group. Results are representative of three independent experiments. Bars: (left) 500 µm; (right) 100 µm. (C) CsA- or vehicle-treated Rag2−/− or WT mice were infected with C. albicans as in A. Homogenates of the kidney were made 4 d after infection and C. albicans quantitated by serial dilution and colony counting. Each dot represents the mean of two measurements taken from a single mouse. P < 0.0001 by comparing either CsA-treated group to the corresponding vehicle-treated group by an unpaired Student’s t test. Results are representative of two independent experiments. Horizontal bars show the mean of the group. Error bars show SD.
Figure 2.
Figure 2.
CnBLysM mice display increased susceptibility to fungal infection. (A) Kaplan-Meier survival curve showing the survival of C. albicans–infected mice. CnBfl/fl or CnBLysM mice were infected with 105C. albicans yeasts by i.v. injection (n = 10–11 mice per group). Mice were then monitored daily for survival. P < 0.0001 by the log-rank test. Results are representative of three independent experiments. (B) CnBLysM or control CnBfl/fl mice were infected with C. albicans as in A. Homogenates of the kidney were made 4 d after infection and C. albicans quantitated by serial dilution and colony counting. Each dot represents the mean of two measurements taken from a single mouse. P < 0.0001 by an unpaired Student’s t test. Results are representative of three independent experiments. Horizontal bars show the mean of the group. Error bars show SD. (C) Histological analysis of the kidneys of C. albicans–infected mice 4 d after challenge. C. albicans were visualized by PAS stain (purple color). Histology is representative of four mice per group. Results are representative of three independent experiments. Bars, 100 µm.
Figure 3.
Figure 3.
Zymosan activates the calcineurin–NFAT pathway. (A) Primary neutrophils were isolated and treated with CsA or vehicle for 15 min before mixing 1:1 with C. albicans yeasts, strain SC 5314. At the indicated time points, aliquots were taken and CFUs of C. albicans determined by serial dilutions on YPD agar. Relative killing was determined by normalization to C. albicans added to medium without neutrophils. Results are representative of three independent experiments. (B) Expression of NFATc1, NFATc2, and NFATc3 was determined in neutrophils and macrophages as indicated by real-time PCR. Results are representative of three independent experiments. (C) Primary neutrophils stimulated with 100 µg/ml zymosan and blotted for expression of NFATc1. Results are representative of three independent assays. (D) Primary neutrophils were stimulated with zymosan for 30 min, and nuclear and cytoplasmic fractions were blotted for NFATc1. Results are representative of three independent experiments. (E) Primary neutrophils were stimulated with the indicated concentrations of zymosan for 12 h, and the supernatant levels of IL-10 and IL-6 were quantified by ELISA. Results are representative of three independent experiments. (F) Primary neutrophils were stimulated with zymosan for 6 h and the expression of Cox2 was determined by real-time PCR. Results are representative of three independent experiments. (G) NFATc1 NFATc3Mx neutrophils and neutrophils from double heterozygous NFATc1Mx/+ NFATc3Mx/+ mice were isolated and stimulated with 100 µg/ml zymosan. 12 h later, supernatants were harvested and IL-10 levels determined by ELISA. Results are representative of three independent experiments. Error bars show SD.
Figure 4.
Figure 4.
Dectin-1, and not TLRs, are upstream of CnB activation. (A) Primary neutrophils from the indicated genotypes were pretreated with CsA for 15 min and stimulated with 100 µg/ml curdlan. IL-10 secretion was determined after 12 h by ELISA. Results are representative of three independent experiments. (B) Primary neutrophils from the indicated genotypes were pretreated with CsA for 15 min and stimulated with 100 µg/ml curdlan. IL-10 secretion was determined after 12 h by ELISA. Results are representative of two independent experiments. Error bars show SD.

References

    1. Aliprantis A.O., Ueki Y., Sulyanto R., Park A., Sigrist K.S., Sharma S.M., Ostrowski M.C., Olsen B.R., Glimcher L.H. 2008. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118:3775–3789 10.1172/JCI35711
    1. Aratani Y., Koyama H., Nyui S., Suzuki K., Kura F., Maeda N. 1999. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. 67:1828–1836
    1. Ariizumi K., Shen G.L., Shikano S., Ritter R., III, Zukas P., Edelbaum D., Morita A., Takashima A. 2000a. Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms. J. Biol. Chem. 275:11957–11963 10.1074/jbc.275.16.11957
    1. Ariizumi K., Shen G.L., Shikano S., Xu S., Ritter R., III, Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., Takashima A. 2000b. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 275:20157–20167 10.1074/jbc.M909512199
    1. Bram R.J., Crabtree G.R. 1994. Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature. 371:355–358 10.1038/371355a0
    1. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., Wong S.Y., Gordon S. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196:407–412 10.1084/jem.20020470
    1. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., Gordon S. 2003. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197:1119–1124 10.1084/jem.20021890
    1. Canté-Barrett K., Winslow M.M., Crabtree G.R. 2007. Selective role of NFATc3 in positive selection of thymocytes. J. Immunol. 179:103–110
    1. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., Förster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265–277 10.1023/A:1008942828960
    1. Clipstone N.A., Crabtree G.R. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:695–697 10.1038/357695a0
    1. Dalmarco E.M., Medeiros Y.S., Fröde T.S. 2008. Cyclosporin A inhibits CD11a/CD18 adhesion molecules due to inhibition of TNFalpha and IL-1 beta levels in the mouse model of pleurisy induced by carrageenan. Cell Adh Migr. 2:231–235
    1. De Rosa F.G., Garazzino S., Pasero D., Di Perri G., Ranieri V.M. 2009. Invasive candidiasis and candidemia: new guidelines. Minerva Anestesiol. 75:453–458
    1. Diekema D.J., Messer S.A., Brueggemann A.B., Coffman S.L., Doern G.V., Herwaldt L.A., Pfaller M.A. 2002. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J. Clin. Microbiol. 40:1298–1302 10.1128/JCM.40.4.1298-1302.2002
    1. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., Kasprowicz D.J., Kellar K., Pare J., van Dyke T., et al. 2006. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116:916–928 10.1172/JCI27203
    1. Farkas S.A., Schnitzbauer A.A., Kirchner G., Obed A., Banas B., Schlitt H.J. 2009. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl. Int. 22:49–60 10.1111/j.1432-2277.2008.00796.x
    1. Goodridge H.S., Simmons R.M., Underhill D.M. 2007. Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol. 178:3107–3115
    1. Gringhuis S.I., den Dunnen J., Litjens M., van der Vlist M., Wevers B., Bruijns S.C., Geijtenbeek T.B. 2009. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat. Immunol. 10:203–213 10.1038/ni.1692
    1. Gross O., Gewies A., Finger K., Schäfer M., Sparwasser T., Peschel C., Förster I., Ruland J. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 442:651–656 10.1038/nature04926
    1. Gross O., Poeck H., Bscheider M., Dostert C., Hannesschläger N., Endres S., Hartmann G., Tardivel A., Schweighoffer E., Tybulewicz V., et al. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature. 459:433–436 10.1038/nature07965
    1. Hara H., Ishihara C., Takeuchi A., Imanishi T., Xue L., Morris S.W., Inui M., Takai T., Shibuya A., Saijo S., et al. 2007. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8:619–629 10.1038/ni1466
    1. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:743–748 10.1038/nature01889
    1. Hogan P.G., Chen L., Nardone J., Rao A. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205–2232 10.1101/gad.1102703
    1. Horsley V., Aliprantis A.O., Polak L., Glimcher L.H., Fuchs E. 2008. NFATc1 balances quiescence and proliferation of skin stem cells. Cell. 132:299–310 10.1016/j.cell.2007.11.047
    1. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:115–122 10.1016/S1074-7613(00)80086-2
    1. Kerrigan A.M., Dennehy K.M., Mourão-Sá D., Faro-Trindade I., Willment J.A., Taylor P.R., Eble J.A., Reis e Sousa C., Brown G.D. 2009. CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J. Immunol. 182:4150–4157 10.4049/jimmunol.0802808
    1. Kühn R., Schwenk F., Aguet M., Rajewsky K. 1995. Inducible gene targeting in mice. Science. 269:1427–1429 10.1126/science.7660125
    1. Lazarevic V., Zullo A.J., Schweitzer M.N., Staton T.L., Gallo E.M., Crabtree G.R., Glimcher L.H. 2009. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10:306–313 10.1038/ni.1696
    1. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630–638 10.1038/ni1460
    1. Losa García J.E., Mateos Rodríguez F., Jiménez López A., Pérez Arellano J.L. 1996. Action of cyclosporin A on mononuclear phagocytes. J. Investig. Allergol. Clin. Immunol. 6:222–231
    1. MacCallum D.M., Castillo L., Brown A.J., Gow N.A., Odds F.C. 2009. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One. 4:e6420 10.1371/journal.pone.0006420
    1. Macian F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5:472–484 10.1038/nri1632
    1. Matsumoto M., Tanaka T., Kaisho T., Sanjo H., Copeland N.G., Gilbert D.J., Jenkins N.A., Akira S. 1999. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J. Immunol. 163:5039–5048
    1. Neilson J.R., Winslow M.M., Hur E.M., Crabtree G.R. 2004. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity. 20:255–266 10.1016/S1074-7613(04)00052-4
    1. Northrop J.P., Ho S.N., Chen L., Thomas D.J., Timmerman L.A., Nolan G.P., Admon A., Crabtree G.R. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature. 369:497–502 10.1038/369497a0
    1. Robinson M.J., Osorio F., Rosas M., Freitas R.P., Schweighoffer E., Gross O., Verbeek J.S., Ruland J., Tybulewicz V., Brown G.D., et al. 2009. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 206:2037–2051 10.1084/jem.20082818
    1. Roilides E., Katsifa H., Tsaparidou S., Stergiopoulou T., Panteliadis C., Walsh T.J. 2000. Interleukin 10 suppresses phagocytic and antihyphal activities of human neutrophils. Cytokine. 12:379–387 10.1006/cyto.1999.0567
    1. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8:39–46 10.1038/ni1425
    1. Schelenz S. 2008. Management of candidiasis in the intensive care unit. J. Antimicrob. Chemother. 61:i31–i34 10.1093/jac/dkm430
    1. Tavares D., Ferreira P., Arala-Chaves M. 2000. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J. Infect. Dis. 182:266–273 10.1086/315674
    1. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., Brown G.D. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:31–38 10.1038/ni1408
    1. Tharayil John G., Shankar V., Talaulikar G., Mathews M.S., Abraham Abraham M., Punnakuzhathil Thomas P., Korula Jacob C. 2003. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation. 75:1544–1551 10.1097/01.TP.0000061610.34110.04
    1. Vecchiarelli A., Cenci E., Marconi P., Rossi R., Riccardi C., Bistoni F. 1989. Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans. J. Med. Microbiol. 30:183–192 10.1099/00222615-30-3-183
    1. Wells C.A., Salvage-Jones J.A., Li X., Hitchens K., Butcher S., Murray R.Z., Beckhouse A.G., Lo Y.L., Manzanero S., Cobbold C., et al. 2008. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 180:7404–7413
    1. Woo M., Przepiorka D., Ippoliti C., Warkentin D., Khouri I., Fritsche H., Körbling M. 1997. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 20:1095–1098 10.1038/sj.bmt.1701027
    1. Xu S., Huo J., Lee K.G., Kurosaki T., Lam K.P. 2009. Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells. J. Biol. Chem. 284:7038–7046 10.1074/jbc.M806650200
    1. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:640–643 10.1126/science.1087262
    1. Yamasaki S., Matsumoto M., Takeuchi O., Matsuzawa T., Ishikawa E., Sakuma M., Tateno H., Uno J., Hirabayashi J., Mikami Y., et al. 2009. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc. Natl. Acad. Sci. USA. 106:1897–1902 10.1073/pnas.0805177106
    1. Zanoni I., Ostuni R., Capuano G., Collini M., Caccia M., Ronchi A.E., Rocchetti M., Mingozzi F., Foti M., Chirico G., et al. 2009. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature. 460:264–268 10.1038/nature08118

Source: PubMed

3
Se inscrever